Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials

Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic... J Interv Card Electrophysiol (2017) 49:263–270 DOI 10.1007/s10840-017-0260-8 REVIEWS Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials 1 2 3 1 Jorge Romero & Rahul Chaudhary & Jalaj Garg & Florentino Lupercio & 3 4 3 3 1,5 Neeraj Shah & Rahul Gupta & Talha Nazir & Babak Bozorgnia & Andrea Natale & 1,5 Luigi Di Biase Received: 10 January 2017 /Accepted: 30 May 2017 /Published online: 3 July 2017 Springer Science+Business Media New York 2017 Abstract Results We analyzed a total of 2573 patients from five RCTs Introduction A mortality benefit in patients with implantable comparing ICD with medical therapy in patients with NICM. cardioverter defibrillator (ICD) in ischemic cardiomyopathy is The mean follow up for the trials was 48 ± 22 months. There well established. However, the benefit of ICD implantation in was a significant reduction in (a) all-cause mortality (RR 0.84, non-ischemic cardiomyopathy (NICM) on total mortality re- 95% CI 0.71–0.99, p = 0.03) and (b) sudden cardiac death (RR mains uncertain. We performed a systematic review and meta- 0.47, 95% CI 0.30–0.73, p < 0.001) in ICD group versus medical analysis of randomized controlled trials http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiac Electrophysiology Springer Journals

Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials

Loading next page...
 
/lp/springer_journal/role-of-implantable-cardioverter-defibrillator-in-non-ischemic-uTHctxH20k
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Cardiology
ISSN
1383-875X
eISSN
1572-8595
D.O.I.
10.1007/s10840-017-0260-8
Publisher site
See Article on Publisher Site

Abstract

J Interv Card Electrophysiol (2017) 49:263–270 DOI 10.1007/s10840-017-0260-8 REVIEWS Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials 1 2 3 1 Jorge Romero & Rahul Chaudhary & Jalaj Garg & Florentino Lupercio & 3 4 3 3 1,5 Neeraj Shah & Rahul Gupta & Talha Nazir & Babak Bozorgnia & Andrea Natale & 1,5 Luigi Di Biase Received: 10 January 2017 /Accepted: 30 May 2017 /Published online: 3 July 2017 Springer Science+Business Media New York 2017 Abstract Results We analyzed a total of 2573 patients from five RCTs Introduction A mortality benefit in patients with implantable comparing ICD with medical therapy in patients with NICM. cardioverter defibrillator (ICD) in ischemic cardiomyopathy is The mean follow up for the trials was 48 ± 22 months. There well established. However, the benefit of ICD implantation in was a significant reduction in (a) all-cause mortality (RR 0.84, non-ischemic cardiomyopathy (NICM) on total mortality re- 95% CI 0.71–0.99, p = 0.03) and (b) sudden cardiac death (RR mains uncertain. We performed a systematic review and meta- 0.47, 95% CI 0.30–0.73, p < 0.001) in ICD group versus medical analysis of randomized controlled trials

Journal

Journal of Interventional Cardiac ElectrophysiologySpringer Journals

Published: Jul 3, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off